Role of molecular testing in the management of HPV H&N cancers
Thursday, June 16, 2016
Head and Neck Session
•
HN 03
•
2:15 PM
>
3:45 PM
•
Role of molecular testing in the management of HPV H&N cancers
•
Wolf Dietrich
Head and Neck Session
•
HN 03-01
•
Further studies on a model for predicting individual clinical outcome in patients with human papillomavirus (HPV) positive tonsillar and base of tongue cancer
See abstract
>
A.
Anders
Näsman
•
HN 03-03
•
Need for standardization
>
P.
Peter
Snijders
•
HN 03-04
•
Which test, and how should it be validated?
>
R.
Ruud
Brakenhoff
•
HN 03-05
•
HPV status and response to Anti-PD-1 therapy
>
M.
Maura
Gillison
•
HN 03-06
•
Clinical prognostic markers for HPV-HNSCC: ADEPT clinical trial
>
B.
Bruce
Haughey
•
HN 03-02
•
PROMISE OF EARLY DETECTION OF HPV-OPC
See abstract
>
T.
Tim
Waterboer
|